Development and validation of the Patient Experience with Treatment and Self-management (PETS): a patient-reported measure of treatment burden.
Eton, David T;
Yost, Kathleen J;
Lai, Jin-Shei;
Ridgeway, Jennifer L;
Egginton, Jason S;
Rosedahl, Jordan K;
Linzer, Mark;
Boehm, Deborah H;
Thakur, Azra;
Poplau, Sara;
+4 more...Odell, Laura;
Montori, Victor M;
May, Carl R;
Anderson, Roger T;
(2017)
Development and validation of the Patient Experience with Treatment and Self-management (PETS): a patient-reported measure of treatment burden.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 26 (2).
pp. 489-503.
ISSN 0962-9343
DOI: https://doi.org/10.1007/s11136-016-1397-0
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
PURPOSE: The purpose of this study was to develop and validate a new comprehensive patient-reported measure of treatment burden-the Patient Experience with Treatment and Self-management (PETS). METHODS: A conceptual framework was used to derive the PETS with items reviewed and cognitively tested with patients. A survey battery, including a pilot version of the PETS, was mailed to 838 multi-morbid patients from two healthcare institutions for validation. RESULTS: A total of 332 multi-morbid patients returned completed surveys. Diagnostics supported deletion and consolidation of some items and domains. Confirmatory factor analysis supported a domain model for scaling comprised of 9 factors: medical information, medications, medical appointments, monitoring health, interpersonal challenges, medical/healthcare expenses, difficulty with healthcare services, role/social activity limitations, and physical/mental exhaustion. Scales showed good internal consistency (α range 0.79-0.95). Higher PETS scores, indicative of greater treatment burden, were correlated with more distress, less satisfaction with medications, lower self-efficacy, worse physical and mental health, and lower convenience of healthcare (Ps < 0.001). Patients with lower health literacy, less adherence to medications, and more financial difficulties reported higher PETS scores (Ps < 0.01). CONCLUSION: A comprehensive patient-reported measure of treatment burden can help to better characterize the impact of treatment and self-management burden on patient well-being and guide care toward minimally disruptive medicine.